Skip to main contentSkip to navigation
Sirius Investors

RBSH Stock: Rebus Holdings, Inc. Stock Price, Analysis & Insights

Get live RBSH stock price $0.00, comprehensive Rebus Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time RBSH stock data and investment insights.

0.00
0.00%Today
RBSHRebus Holdings, Inc. • Other OTC • Healthcare
Market Cap
3.21K
Volume
33.94K
52W High
0.00
52W Low
0.00

Loading chart data...

Rebus Holdings, Inc. (RBSH) Overview

Rebus Holdings, Inc. (RBSH) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, RBSH trades at $0.00 with a market capitalization of 3.21K . Over the past 52 weeks, RBSH has traded between $0.00 and $0.00 , with the current price positioned at approximately NaN% of this range . The stock currently trades at a...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 3.21K
  • Current price: $0.00
  • 52-week range: $0.00 - $0.00
  • P/E ratio: 0.01

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is...

Company Information

CEO
Raul Silvestre
Sector
Healthcare
Industry
Biotechnology
Employees
1

Contact Information

Address
2629 Townsgate Road
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 0.0)

Higher growth potential with elevated volatility (Beta: 10.00)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Rebus Holdings, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Rebus Holdings, Inc.
  • Investors should consider how Rebus Holdings, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

3.21K

P/E Ratio (TTM)

0.01

Beta

10.00

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.